世界の拡張型心筋症用治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Dilated Cardiomyopathy Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4137 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、拡張型心筋症用治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（薬剤クラス、植込み型デバイス、パイプライン分析）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・拡張型心筋症用治療薬の市場動向 ・企業の競争状況、市場シェア ・拡張型心筋症用治療薬の種類別市場規模と予測2016-2027（薬剤クラス、植込み型デバイス、パイプライン分析） ・拡張型心筋症用治療薬の用途別市場規模と予測2016-2027（病院、診療所、その他） ・拡張型心筋症用治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・拡張型心筋症用治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・拡張型心筋症用治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・拡張型心筋症用治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・拡張型心筋症用治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Aastrom Biosciences、Capricor Therapeutics、GlaxoSmithkline Plc、Johnson and Johnson、Kasiak Research Pvt. Ltd.、Merck & Co., Inc.、MyoKardia, Pfizer, Inc.、t2cure, GmbH、Teva Pharmaceutical Industries、ZensunSci & Tech） ・結論

Dilated cardiomyopathy (DCM) is a condition in which the heart’s ability to pump blood is decreased because the heart’s main pumping chamber, the left ventricle, is enlarged and weakened. In some cases, it prevents the heart from relaxing and filling with blood as it should.

Market Analysis and Insights: Global Dilated Cardiomyopathy Therapeutics Market
The global Dilated Cardiomyopathy Therapeutics market size is projected to reach US$ 34 million by 2027, from US$ 27 million in 2020, at a CAGR of 2.7% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Dilated Cardiomyopathy Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Dilated Cardiomyopathy Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Dilated Cardiomyopathy Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Dilated Cardiomyopathy Therapeutics market.

Global Dilated Cardiomyopathy Therapeutics Scope and Market Size
Dilated Cardiomyopathy Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Dilated Cardiomyopathy Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Drug Class
Implantable Device
Pipeline Analysis

Segment by Application
Hospitals
Clinic
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Aastrom Biosciences
Capricor Therapeutics
GlaxoSmithkline Plc
Johnson and Johnson
Kasiak Research Pvt. Ltd.
Merck & Co., Inc.
MyoKardia, Pfizer, Inc.
t2cure, GmbH
Teva Pharmaceutical Industries
ZensunSci & Tech

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Dilated Cardiomyopathy Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Drug Class
1.2.3 Implantable Device
1.2.4 Pipeline Analysis
1.3 Market by Application
1.3.1 Global Dilated Cardiomyopathy Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Dilated Cardiomyopathy Therapeutics Market Perspective (2016-2027)
2.2 Dilated Cardiomyopathy Therapeutics Growth Trends by Regions
2.2.1 Dilated Cardiomyopathy Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Dilated Cardiomyopathy Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Dilated Cardiomyopathy Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Dilated Cardiomyopathy Therapeutics Industry Dynamic
2.3.1 Dilated Cardiomyopathy Therapeutics Market Trends
2.3.2 Dilated Cardiomyopathy Therapeutics Market Drivers
2.3.3 Dilated Cardiomyopathy Therapeutics Market Challenges
2.3.4 Dilated Cardiomyopathy Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Dilated Cardiomyopathy Therapeutics Players by Revenue
3.1.1 Global Top Dilated Cardiomyopathy Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Dilated Cardiomyopathy Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Dilated Cardiomyopathy Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Dilated Cardiomyopathy Therapeutics Revenue
3.4 Global Dilated Cardiomyopathy Therapeutics Market Concentration Ratio
3.4.1 Global Dilated Cardiomyopathy Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Dilated Cardiomyopathy Therapeutics Revenue in 2020
3.5 Dilated Cardiomyopathy Therapeutics Key Players Head office and Area Served
3.6 Key Players Dilated Cardiomyopathy Therapeutics Product Solution and Service
3.7 Date of Enter into Dilated Cardiomyopathy Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Dilated Cardiomyopathy Therapeutics Breakdown Data by Type
4.1 Global Dilated Cardiomyopathy Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Dilated Cardiomyopathy Therapeutics Forecasted Market Size by Type (2022-2027)

5 Dilated Cardiomyopathy Therapeutics Breakdown Data by Application
5.1 Global Dilated Cardiomyopathy Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Dilated Cardiomyopathy Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Dilated Cardiomyopathy Therapeutics Market Size (2016-2027)
6.2 North America Dilated Cardiomyopathy Therapeutics Market Size by Type
6.2.1 North America Dilated Cardiomyopathy Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Dilated Cardiomyopathy Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Dilated Cardiomyopathy Therapeutics Market Size by Type (2016-2027)
6.3 North America Dilated Cardiomyopathy Therapeutics Market Size by Application
6.3.1 North America Dilated Cardiomyopathy Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Dilated Cardiomyopathy Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Dilated Cardiomyopathy Therapeutics Market Size by Application (2016-2027)
6.4 North America Dilated Cardiomyopathy Therapeutics Market Size by Country
6.4.1 North America Dilated Cardiomyopathy Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Dilated Cardiomyopathy Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Dilated Cardiomyopathy Therapeutics Market Size (2016-2027)
7.2 Europe Dilated Cardiomyopathy Therapeutics Market Size by Type
7.2.1 Europe Dilated Cardiomyopathy Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Dilated Cardiomyopathy Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Dilated Cardiomyopathy Therapeutics Market Size by Type (2016-2027)
7.3 Europe Dilated Cardiomyopathy Therapeutics Market Size by Application
7.3.1 Europe Dilated Cardiomyopathy Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Dilated Cardiomyopathy Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Dilated Cardiomyopathy Therapeutics Market Size by Application (2016-2027)
7.4 Europe Dilated Cardiomyopathy Therapeutics Market Size by Country
7.4.1 Europe Dilated Cardiomyopathy Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Dilated Cardiomyopathy Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Dilated Cardiomyopathy Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Dilated Cardiomyopathy Therapeutics Market Size by Type
8.2.1 Asia-Pacific Dilated Cardiomyopathy Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Dilated Cardiomyopathy Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Dilated Cardiomyopathy Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Dilated Cardiomyopathy Therapeutics Market Size by Application
8.3.1 Asia-Pacific Dilated Cardiomyopathy Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Dilated Cardiomyopathy Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Dilated Cardiomyopathy Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Dilated Cardiomyopathy Therapeutics Market Size by Region
8.4.1 Asia-Pacific Dilated Cardiomyopathy Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Dilated Cardiomyopathy Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Dilated Cardiomyopathy Therapeutics Market Size (2016-2027)
9.2 Latin America Dilated Cardiomyopathy Therapeutics Market Size by Type
9.2.1 Latin America Dilated Cardiomyopathy Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Dilated Cardiomyopathy Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Dilated Cardiomyopathy Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Dilated Cardiomyopathy Therapeutics Market Size by Application
9.3.1 Latin America Dilated Cardiomyopathy Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Dilated Cardiomyopathy Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Dilated Cardiomyopathy Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Dilated Cardiomyopathy Therapeutics Market Size by Country
9.4.1 Latin America Dilated Cardiomyopathy Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Dilated Cardiomyopathy Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Dilated Cardiomyopathy Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Dilated Cardiomyopathy Therapeutics Market Size by Type
10.2.1 Middle East & Africa Dilated Cardiomyopathy Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Dilated Cardiomyopathy Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Dilated Cardiomyopathy Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Dilated Cardiomyopathy Therapeutics Market Size by Application
10.3.1 Middle East & Africa Dilated Cardiomyopathy Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Dilated Cardiomyopathy Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Dilated Cardiomyopathy Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Dilated Cardiomyopathy Therapeutics Market Size by Country
10.4.1 Middle East & Africa Dilated Cardiomyopathy Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Dilated Cardiomyopathy Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Aastrom Biosciences
11.1.1 Aastrom Biosciences Company Details
11.1.2 Aastrom Biosciences Business Overview
11.1.3 Aastrom Biosciences Dilated Cardiomyopathy Therapeutics Introduction
11.1.4 Aastrom Biosciences Revenue in Dilated Cardiomyopathy Therapeutics Business (2016-2021)
11.1.5 Aastrom Biosciences Recent Development
11.2 Capricor Therapeutics
11.2.1 Capricor Therapeutics Company Details
11.2.2 Capricor Therapeutics Business Overview
11.2.3 Capricor Therapeutics Dilated Cardiomyopathy Therapeutics Introduction
11.2.4 Capricor Therapeutics Revenue in Dilated Cardiomyopathy Therapeutics Business (2016-2021)
11.2.5 Capricor Therapeutics Recent Development
11.3 GlaxoSmithkline Plc
11.3.1 GlaxoSmithkline Plc Company Details
11.3.2 GlaxoSmithkline Plc Business Overview
11.3.3 GlaxoSmithkline Plc Dilated Cardiomyopathy Therapeutics Introduction
11.3.4 GlaxoSmithkline Plc Revenue in Dilated Cardiomyopathy Therapeutics Business (2016-2021)
11.3.5 GlaxoSmithkline Plc Recent Development
11.4 Johnson and Johnson
11.4.1 Johnson and Johnson Company Details
11.4.2 Johnson and Johnson Business Overview
11.4.3 Johnson and Johnson Dilated Cardiomyopathy Therapeutics Introduction
11.4.4 Johnson and Johnson Revenue in Dilated Cardiomyopathy Therapeutics Business (2016-2021)
11.4.5 Johnson and Johnson Recent Development
11.5 Kasiak Research Pvt. Ltd.
11.5.1 Kasiak Research Pvt. Ltd. Company Details
11.5.2 Kasiak Research Pvt. Ltd. Business Overview
11.5.3 Kasiak Research Pvt. Ltd. Dilated Cardiomyopathy Therapeutics Introduction
11.5.4 Kasiak Research Pvt. Ltd. Revenue in Dilated Cardiomyopathy Therapeutics Business (2016-2021)
11.5.5 Kasiak Research Pvt. Ltd. Recent Development
11.6 Merck & Co., Inc.
11.6.1 Merck & Co., Inc. Company Details
11.6.2 Merck & Co., Inc. Business Overview
11.6.3 Merck & Co., Inc. Dilated Cardiomyopathy Therapeutics Introduction
11.6.4 Merck & Co., Inc. Revenue in Dilated Cardiomyopathy Therapeutics Business (2016-2021)
11.6.5 Merck & Co., Inc. Recent Development
11.7 MyoKardia, Pfizer, Inc.
11.7.1 MyoKardia, Pfizer, Inc. Company Details
11.7.2 MyoKardia, Pfizer, Inc. Business Overview
11.7.3 MyoKardia, Pfizer, Inc. Dilated Cardiomyopathy Therapeutics Introduction
11.7.4 MyoKardia, Pfizer, Inc. Revenue in Dilated Cardiomyopathy Therapeutics Business (2016-2021)
11.7.5 MyoKardia, Pfizer, Inc. Recent Development
11.8 t2cure, GmbH
11.8.1 t2cure, GmbH Company Details
11.8.2 t2cure, GmbH Business Overview
11.8.3 t2cure, GmbH Dilated Cardiomyopathy Therapeutics Introduction
11.8.4 t2cure, GmbH Revenue in Dilated Cardiomyopathy Therapeutics Business (2016-2021)
11.8.5 t2cure, GmbH Recent Development
11.9 Teva Pharmaceutical Industries
11.9.1 Teva Pharmaceutical Industries Company Details
11.9.2 Teva Pharmaceutical Industries Business Overview
11.9.3 Teva Pharmaceutical Industries Dilated Cardiomyopathy Therapeutics Introduction
11.9.4 Teva Pharmaceutical Industries Revenue in Dilated Cardiomyopathy Therapeutics Business (2016-2021)
11.9.5 Teva Pharmaceutical Industries Recent Development
11.10 ZensunSci & Tech
11.10.1 ZensunSci & Tech Company Details
11.10.2 ZensunSci & Tech Business Overview
11.10.3 ZensunSci & Tech Dilated Cardiomyopathy Therapeutics Introduction
11.10.4 ZensunSci & Tech Revenue in Dilated Cardiomyopathy Therapeutics Business (2016-2021)
11.10.5 ZensunSci & Tech Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Dilated Cardiomyopathy Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Drug Class
Table 3. Key Players of Implantable Device
Table 4. Key Players of Pipeline Analysis
Table 5. Global Dilated Cardiomyopathy Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Dilated Cardiomyopathy Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Dilated Cardiomyopathy Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Dilated Cardiomyopathy Therapeutics Market Share by Regions (2016-2021)
Table 9. Global Dilated Cardiomyopathy Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Dilated Cardiomyopathy Therapeutics Market Share by Regions (2022-2027)
Table 11. Dilated Cardiomyopathy Therapeutics Market Trends
Table 12. Dilated Cardiomyopathy Therapeutics Market Drivers
Table 13. Dilated Cardiomyopathy Therapeutics Market Challenges
Table 14. Dilated Cardiomyopathy Therapeutics Market Restraints
Table 15. Global Dilated Cardiomyopathy Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Dilated Cardiomyopathy Therapeutics Market Share by Players (2016-2021)
Table 17. Global Top Dilated Cardiomyopathy Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dilated Cardiomyopathy Therapeutics as of 2020)
Table 18. Ranking of Global Top Dilated Cardiomyopathy Therapeutics Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Dilated Cardiomyopathy Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Dilated Cardiomyopathy Therapeutics Product Solution and Service
Table 22. Date of Enter into Dilated Cardiomyopathy Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Dilated Cardiomyopathy Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Dilated Cardiomyopathy Therapeutics Revenue Market Share by Type (2016-2021)
Table 26. Global Dilated Cardiomyopathy Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Dilated Cardiomyopathy Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Dilated Cardiomyopathy Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Dilated Cardiomyopathy Therapeutics Revenue Market Share by Application (2016-2021)
Table 30. Global Dilated Cardiomyopathy Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Dilated Cardiomyopathy Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Dilated Cardiomyopathy Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Dilated Cardiomyopathy Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Dilated Cardiomyopathy Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Dilated Cardiomyopathy Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Dilated Cardiomyopathy Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Dilated Cardiomyopathy Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Dilated Cardiomyopathy Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Dilated Cardiomyopathy Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Dilated Cardiomyopathy Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Dilated Cardiomyopathy Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Dilated Cardiomyopathy Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Dilated Cardiomyopathy Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Dilated Cardiomyopathy Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Dilated Cardiomyopathy Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Dilated Cardiomyopathy Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Dilated Cardiomyopathy Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Dilated Cardiomyopathy Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Dilated Cardiomyopathy Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Dilated Cardiomyopathy Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Dilated Cardiomyopathy Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Dilated Cardiomyopathy Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Dilated Cardiomyopathy Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Dilated Cardiomyopathy Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Dilated Cardiomyopathy Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Dilated Cardiomyopathy Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Dilated Cardiomyopathy Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Dilated Cardiomyopathy Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Dilated Cardiomyopathy Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Dilated Cardiomyopathy Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Dilated Cardiomyopathy Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 62. Aastrom Biosciences Company Details
Table 63. Aastrom Biosciences Business Overview
Table 64. Aastrom Biosciences Dilated Cardiomyopathy Therapeutics Product
Table 65. Aastrom Biosciences Revenue in Dilated Cardiomyopathy Therapeutics Business (2016-2021) & (US$ Million)
Table 66. Aastrom Biosciences Recent Development
Table 67. Capricor Therapeutics Company Details
Table 68. Capricor Therapeutics Business Overview
Table 69. Capricor Therapeutics Dilated Cardiomyopathy Therapeutics Product
Table 70. Capricor Therapeutics Revenue in Dilated Cardiomyopathy Therapeutics Business (2016-2021) & (US$ Million)
Table 71. Capricor Therapeutics Recent Development
Table 72. GlaxoSmithkline Plc Company Details
Table 73. GlaxoSmithkline Plc Business Overview
Table 74. GlaxoSmithkline Plc Dilated Cardiomyopathy Therapeutics Product
Table 75. GlaxoSmithkline Plc Revenue in Dilated Cardiomyopathy Therapeutics Business (2016-2021) & (US$ Million)
Table 76. GlaxoSmithkline Plc Recent Development
Table 77. Johnson and Johnson Company Details
Table 78. Johnson and Johnson Business Overview
Table 79. Johnson and Johnson Dilated Cardiomyopathy Therapeutics Product
Table 80. Johnson and Johnson Revenue in Dilated Cardiomyopathy Therapeutics Business (2016-2021) & (US$ Million)
Table 81. Johnson and Johnson Recent Development
Table 82. Kasiak Research Pvt. Ltd. Company Details
Table 83. Kasiak Research Pvt. Ltd. Business Overview
Table 84. Kasiak Research Pvt. Ltd. Dilated Cardiomyopathy Therapeutics Product
Table 85. Kasiak Research Pvt. Ltd. Revenue in Dilated Cardiomyopathy Therapeutics Business (2016-2021) & (US$ Million)
Table 86. Kasiak Research Pvt. Ltd. Recent Development
Table 87. Merck & Co., Inc. Company Details
Table 88. Merck & Co., Inc. Business Overview
Table 89. Merck & Co., Inc. Dilated Cardiomyopathy Therapeutics Product
Table 90. Merck & Co., Inc. Revenue in Dilated Cardiomyopathy Therapeutics Business (2016-2021) & (US$ Million)
Table 91. Merck & Co., Inc. Recent Development
Table 92. MyoKardia, Pfizer, Inc. Company Details
Table 93. MyoKardia, Pfizer, Inc. Business Overview
Table 94. MyoKardia, Pfizer, Inc. Dilated Cardiomyopathy Therapeutics Product
Table 95. MyoKardia, Pfizer, Inc. Revenue in Dilated Cardiomyopathy Therapeutics Business (2016-2021) & (US$ Million)
Table 96. MyoKardia, Pfizer, Inc. Recent Development
Table 97. t2cure, GmbH Company Details
Table 98. t2cure, GmbH Business Overview
Table 99. t2cure, GmbH Revenue in Dilated Cardiomyopathy Therapeutics Business (2016-2021) & (US$ Million)
Table 100. t2cure, GmbH Recent Development
Table 101. Teva Pharmaceutical Industries Company Details
Table 102. Teva Pharmaceutical Industries Business Overview
Table 103. Teva Pharmaceutical Industries Dilated Cardiomyopathy Therapeutics Product
Table 104. Teva Pharmaceutical Industries Revenue in Dilated Cardiomyopathy Therapeutics Business (2016-2021) & (US$ Million)
Table 105. Teva Pharmaceutical Industries Recent Development
Table 106. ZensunSci & Tech Company Details
Table 107. ZensunSci & Tech Business Overview
Table 108. ZensunSci & Tech Dilated Cardiomyopathy Therapeutics Product
Table 109. ZensunSci & Tech Revenue in Dilated Cardiomyopathy Therapeutics Business (2016-2021) & (US$ Million)
Table 110. ZensunSci & Tech Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Dilated Cardiomyopathy Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Drug Class Features
Figure 3. Implantable Device Features
Figure 4. Pipeline Analysis Features
Figure 5. Global Dilated Cardiomyopathy Therapeutics Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinic Case Studies
Figure 8. Others Case Studies
Figure 9. Dilated Cardiomyopathy Therapeutics Report Years Considered
Figure 10. Global Dilated Cardiomyopathy Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Dilated Cardiomyopathy Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Dilated Cardiomyopathy Therapeutics Market Share by Regions: 2020 VS 2027
Figure 13. Global Dilated Cardiomyopathy Therapeutics Market Share by Regions (2022-2027)
Figure 14. Global Dilated Cardiomyopathy Therapeutics Market Share by Players in 2020
Figure 15. Global Top Dilated Cardiomyopathy Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dilated Cardiomyopathy Therapeutics as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Dilated Cardiomyopathy Therapeutics Revenue in 2020
Figure 17. Global Dilated Cardiomyopathy Therapeutics Revenue Market Share by Type (2016-2021)
Figure 18. Global Dilated Cardiomyopathy Therapeutics Revenue Market Share by Type (2022-2027)
Figure 19. North America Dilated Cardiomyopathy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Dilated Cardiomyopathy Therapeutics Market Share by Type (2016-2027)
Figure 21. North America Dilated Cardiomyopathy Therapeutics Market Share by Application (2016-2027)
Figure 22. North America Dilated Cardiomyopathy Therapeutics Market Share by Country (2016-2027)
Figure 23. United States Dilated Cardiomyopathy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Dilated Cardiomyopathy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Dilated Cardiomyopathy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Dilated Cardiomyopathy Therapeutics Market Share by Type (2016-2027)
Figure 27. Europe Dilated Cardiomyopathy Therapeutics Market Share by Application (2016-2027)
Figure 28. Europe Dilated Cardiomyopathy Therapeutics Market Share by Country (2016-2027)
Figure 29. Germany Dilated Cardiomyopathy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Dilated Cardiomyopathy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Dilated Cardiomyopathy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Dilated Cardiomyopathy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Dilated Cardiomyopathy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Dilated Cardiomyopathy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Dilated Cardiomyopathy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Dilated Cardiomyopathy Therapeutics Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Dilated Cardiomyopathy Therapeutics Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Dilated Cardiomyopathy Therapeutics Market Share by Region (2016-2027)
Figure 39. China Dilated Cardiomyopathy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Dilated Cardiomyopathy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Dilated Cardiomyopathy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Dilated Cardiomyopathy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Dilated Cardiomyopathy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Dilated Cardiomyopathy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Dilated Cardiomyopathy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Dilated Cardiomyopathy Therapeutics Market Share by Type (2016-2027)
Figure 47. Latin America Dilated Cardiomyopathy Therapeutics Market Share by Application (2016-2027)
Figure 48. Latin America Dilated Cardiomyopathy Therapeutics Market Share by Country (2016-2027)
Figure 49. Mexico Dilated Cardiomyopathy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Dilated Cardiomyopathy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Dilated Cardiomyopathy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Dilated Cardiomyopathy Therapeutics Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Dilated Cardiomyopathy Therapeutics Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Dilated Cardiomyopathy Therapeutics Market Share by Country (2016-2027)
Figure 55. Turkey Dilated Cardiomyopathy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Dilated Cardiomyopathy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Dilated Cardiomyopathy Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Aastrom Biosciences Revenue Growth Rate in Dilated Cardiomyopathy Therapeutics Business (2016-2021)
Figure 59. Capricor Therapeutics Revenue Growth Rate in Dilated Cardiomyopathy Therapeutics Business (2016-2021)
Figure 60. GlaxoSmithkline Plc Revenue Growth Rate in Dilated Cardiomyopathy Therapeutics Business (2016-2021)
Figure 61. Johnson and Johnson Revenue Growth Rate in Dilated Cardiomyopathy Therapeutics Business (2016-2021)
Figure 62. Kasiak Research Pvt. Ltd. Revenue Growth Rate in Dilated Cardiomyopathy Therapeutics Business (2016-2021)
Figure 63. Merck & Co., Inc. Revenue Growth Rate in Dilated Cardiomyopathy Therapeutics Business (2016-2021)
Figure 64. MyoKardia, Pfizer, Inc. Revenue Growth Rate in Dilated Cardiomyopathy Therapeutics Business (2016-2021)
Figure 65. t2cure, GmbH Revenue Growth Rate in Dilated Cardiomyopathy Therapeutics Business (2016-2021)
Figure 66. Teva Pharmaceutical Industries Revenue Growth Rate in Dilated Cardiomyopathy Therapeutics Business (2016-2021)
Figure 67. ZensunSci & Tech Revenue Growth Rate in Dilated Cardiomyopathy Therapeutics Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

---